Holen Sie sich die Stockscreener-App
11.43
0.35%
-0.04
Schlusskurs vom Vortag:
$11.47
Offen:
$11.43
24-Stunden-Volumen:
1.58M
Relative Volume:
0.93
Marktkapitalisierung:
$1.34B
Einnahmen:
$260.81M
Nettoeinkommen (Verlust:
$20.48M
KGV:
87.92
EPS:
0.13
Netto-Cashflow:
$22.67M
1W Leistung:
+3.44%
1M Leistung:
+10.12%
6M Leistung:
+16.63%
1J Leistung:
-9.72%
1-Tages-Spanne:
$11.33
$11.53
1-Wochen-Bereich:
$10.69
$11.58
52-Wochen-Spanne:
$9.20
$14.63
Dynavax Technologies Corp Stock (DVAX) Company Profile
Firmenname
Dynavax Technologies Corp
Sektor
Telefon
(510) 848-5100
Adresse
2100 POWELL STREET, EMERYVILLE, CA
Vergleichen Sie DVAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
11.43 | 1.35B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
127.69 | 56.36B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.52 | 45.81B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.76 | 43.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
26.32 | 28.67B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
488.43 | 20.92B | 3.08B | 1.24B | 1.07B | 25.61 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-11 | Herabstufung | Goldman | Neutral → Sell |
| 2024-02-01 | Eingeleitet | Goldman | Neutral |
| 2022-09-27 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-01-06 | Fortgesetzt | Goldman | Buy |
| 2021-08-06 | Eingeleitet | Goldman | Buy |
| 2020-08-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-03 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-15 | Eingeleitet | Evercore ISI | Outperform |
| 2019-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-07-11 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-02-27 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-05-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-03-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-02-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-09-25 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-09-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-07-31 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-07-31 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-05-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-04-28 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2016-04-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2013-11-25 | Hochstufung | MLV & Co | Hold → Buy |
| 2013-02-25 | Herabstufung | MLV & Co | Buy → Hold |
| 2012-11-16 | Bestätigt | MLV & Co | Buy |
Alle ansehen
Dynavax Technologies Corp Aktie (DVAX) Neueste Nachrichten
Dynavax Technologies Corporation (NASDAQ:DVAX) Receives $24.33 Average Price Target from Analysts - Defense World
First Week of July 2026 Options Trading For Dynavax Technologies (DVAX) - Nasdaq
Dynavax Technologies Corp (DYF1.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Dynavax Technologies Corporatio (DVAX) Stock forecasts - Yahoo Finance UK
Dynavax Technologies Corporation (0IDA.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Dynavax Technologies Corporation (DYF1) stock a defensive play amid uncertainty2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Dynavax (Nasdaq: DVAX) to Join Evercore Healthcare Conference Fireside Chat on Dec. 2 - Stock Titan
Why Dynavax Technologies Corporation (DYF1) stock remains top ratedRate Hike & Low Risk Entry Point Tips - newser.com
Can Dynavax Technologies Corporation stock deliver consistent earnings growthWeekly Risk Summary & Precise Trade Entry Recommendations - newser.com
Is Dynavax Technologies Corporation showing signs of accumulation2025 Price Targets & Long-Term Investment Growth Plans - newser.com
Why Dynavax Technologies Corporation (DYF1) stock fits value portfoliosTake Profit & Technical Pattern Based Buy Signals - newser.com
Campbell & CO Investment Adviser LLC Sells 24,624 Shares of Dynavax Technologies Corporation $DVAX - Defense World
Can Dynavax Technologies Corporation stock reach $100 price targetSell Signal & Smart Allocation Stock Tips - newser.com
How Dynavax Technologies Corporation stock responds to policy changesWeekly Market Report & Low Drawdown Momentum Ideas - newser.com
Vaxart, Inc. Enters Exclusive License Agreement with Dynavax for COVID-19 Oral Vaccine Candidate, Completes Phase 2b Enrollment and Reports Q3 2025 Financial Results - Quiver Quantitative
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results - Yahoo Finance
What institutional flow reveals about Dynavax Technologies CorporationWeekly Profit Report & Low Drawdown Investment Ideas - newser.com
Is Dynavax Technologies Corporation (DYF1) stock protected from inflationJuly 2025 Setups & AI Enhanced Trading Signals - newser.com
What dividend safety score for Dynavax Technologies Corporation stockInflation Watch & Verified Technical Signals - newser.com
What analysts say about Dynavax Technologies Corporation DYF1 stockDividend Growth Stocks & Trusted Financial Advisors at No Cost - earlytimes.in
What MACD and RSI say about Dynavax Technologies CorporationDollar Strength & Growth Focused Investment Plans - newser.com
Dynavax Technologies Corporatio (DVAX) Stock Forecasts - Yahoo Finance
Dynavax Technologies Corporation (NASDAQ:DVAX) Q3 2025 Earnings Call Transcript - Insider Monkey
Why Dynavax Technologies (DVAX) Is Up 5.7% After Launching a $100 Million Buyback and Raising Guidance - Yahoo Finance
Dynavax targets 60% U.S. hepatitis B market share by 2030 amid new COVID-19 vaccine deal and expanded share repurchase - MSN
Predicting Dynavax Technologies Corporation trend using moving averagesJuly 2025 Update & Fast Exit Strategy with Risk Control - newser.com
Will Dynavax Technologies Corporation stock remain a Wall Street favoriteWeekly Gains Summary & Weekly Breakout Stock Alerts - newser.com
Chart overlay techniques for tracking Dynavax Technologies CorporationEarnings Overview Report & Low Risk High Win Rate Picks - newser.com
Dynavax posts 13% rise in HEPLISAV-B revenue, announces $100 million buyback - Investing.com Nigeria
Dynavax Technologies: Q3 Earnings Snapshot - ctinsider.com
Finanzdaten der Dynavax Technologies Corp-Aktie (DVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dynavax Technologies Corp-Aktie (DVAX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Maste | 10% Owner |
Aug 21 '25 |
Sale |
11.03 |
1,094,994 |
12,077,784 |
16,696,492 |
| Deep Track Biotechnology Maste | 10% Owner |
Aug 22 '25 |
Sale |
10.59 |
970,143 |
10,273,814 |
15,726,349 |
| Novack David F | President & COO |
Mar 24 '25 |
Option Exercise |
6.80 |
10,000 |
68,050 |
18,078 |
| Novack David F | President & COO |
Mar 24 '25 |
Sale |
14.00 |
10,000 |
140,000 |
8,078 |
3.53%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):